[Hepatic tumors].
In this paper aspects concerning epidemiology, pathophysiology, laboratory diagnosis and treatment modalities of primary hepatomas and secondary tumors of the liver are discussed. As results obtained with conventional chemotherapy are unsatisfying special emphasis is put on the new therapeutic methods of intraarterial and intravenous cytostatic perfusion via hepatic artery and portal vein respectively. Additionally our own clinical and laboratory datas are presented.
D000792:Angiography; D001943:Breast Neoplasms / Q000556:secondary; D001984:Bronchial Neoplasms / Q000556:secondary; D002272:Carcinoembryonic Antigen / Q000032:analysis; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000628:therapy; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D005770:Gastrointestinal Neoplasms / Q000556:secondary; D006801:Humans; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000556:secondary* / Q000628:therapy; D008297:Male; D011877:Radionuclide Imaging; D014463:Ultrasonography; D000509:alpha-Fetoproteins / Q000032:analysis
D002272:Carcinoembryonic Antigen; D000509:alpha-Fetoproteins; D004317:Doxorubicin; D005472:Fluorouracil
Hepatale Tumoren.